The partnership combines the EOPatch, a third-party continuous glucose monitor (CGM), and Diabeloop’s automated insulin delivery algorithm – with both integrating into Diabeloop’s currently under-development smartphone app.
All three components of the planned automated insulin delivery system have already received CE mark in Europe, with Diabeloop earmarking a commercial launch for the end of 2023.
“It is an honor to partner with EOFlow and combine our state-of-the-art automated insulin delivery algorithm with their innovative wearable insulin pump solution. Diabeloop and EOFlow share the same goal to offer choices to people living with diabetes by providing advanced and user-friendly solutions,” said Diabeloop co-founder and CEO Herik Huneker.
To read more CLICK HERE.